Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Infection and Immunity

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.70.11.6284-6293.2002PMID 12379707PMCID PMC130311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-10-Deficient Mice Demonstrate Multiple Organ Failure and Increased Mortality During Escherichia coli Peritonitis Despite an Accelerated Bacterial Clearance1

  2001cited by this paper
• The Role of IL-10 in Promoting Disease Progression in Leishmaniasis1

  2001cited by this paper
• Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis

  2001influential reference
• The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure

  2001cited by this paper
• Endogenous Interleukin-10 Is Required for Prevention of a Hyperinflammatory Intracerebral Immune Response in Listeria monocytogenes Meningoencephalitis

  2001cited by this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• Tissue cytokine responses in canine visceral leishmaniasis.

  2001cited by this paper
• Immunomodulatory Role of Interleukin-10 in Visceral Leishmaniasis: Defective Activation of Protein Kinase C-Mediated Signal Transduction Events

  2001cited by this paper
• Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines.

  2001cited by this paper
• Associations of peak shifts in age--prevalence for human malarias with bednet coverage.

  2001cited by this paper
• Tissue granuloma structure‐function in experimental visceral leishmaniasis

  2001cited by this paper
• IL‐10 mediates susceptibility to Leishmania donovani infection

  2001cited by this paper
• IL‐12 gene‐deficient C57BL / 6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology

  2000cited by this paper
• Anti–Interleukin 10 Receptor Monoclonal Antibody Is an Adjuvant for T Helper Cell Type 1 Responses to Soluble Antigen Only in the Presence of Lipopolysaccharide

  2000cited by this paper
• Immunopathologic Effects of Tumor Necrosis Factor Alpha in Murine Mycobacterial Infection Are Dose Dependent

  2000cited by this paper
• Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment

  2000cited by this paper
• IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis.

  2000cited by this paper
• Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral Leishmaniasis

  2000cited by this paper
• Signal Transduction Events Activation of Protein Kinase C-Mediated Visceral Leishmaniasis : Defective Immunomodulatory Role of Interleukin-10 in

  2000cited by this paper
• Mononuclear Cell Recruitment, Granuloma Assembly, and Response to Treatment in Experimental Visceral Leishmaniasis: Intracellular Adhesion Molecule 1-Dependent and -Independent Regulation

  2000cited by this paper
• Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.

  2000cited by this paper
• Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.

  2000cited by this paper
• Experimental Leishmania major infection in mice: role of IL‐10

  1999cited by this paper
• Macrophage Microbicidal Mechanisms In Vivo: Reactive Nitrogen versus Oxygen Intermediates in the Killing of Intracellular Visceral Leishmania donovani

  1999cited by this paper
• An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation

  1999cited by this paper
• A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells.

  1999cited by this paper
• Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis.

  1999influential reference
• Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar.

  1998cited by this paper
• Splenic cytokine responses in Indian kala-azar before and after treatment.

  1998cited by this paper
• Regional Differences in the Cellular Immune Response to Experimental Cutaneous or Visceral Infection withLeishmania donovani

  1998cited by this paper
• Cloning of Syrian Hamster (Mesocricetus auratus) Cytokine cDNAs and Analysis of Cytokine mRNA Expression in Experimental Visceral Leishmaniasis

  1998cited by this paper
• The importance of TGF-beta in murine visceral leishmaniasis.

  1998cited by this paper
• Neutralization of IL‐12 demonstrates the existence of discrete organ‐specific phases in the control of Leishmania donovani

  1998cited by this paper
• High levels of plasma IL‐10 and expression of IL‐10 by keratinocytes during visceral leishmaniasis predict subsequent development of post‐kala‐azar dermal leishmaniasis

  1998cited by this paper
• Presence of circulating levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis.

  1998cited by this paper
• Behavior of  Visceral Leishmania donovani in an Experimentally Induced T Helper Cell 2 (Th2)-Associated Response Model

  1997cited by this paper
• Modulating ongoing Th2-cell responses in experimental leishmaniasis.

  1997cited by this paper
• T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection.

  1997cited by this paper
• Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis.

  1997cited by this paper
• Response to interferon-γ plus pentavalent antimony in Indian visceral leishmaniasis

  1997cited by this paper
• Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis.

  1997cited by this paper
• Intracellular Antimicrobial Activity in the Absence of Interferon-γ: Effect of Interleukin-12 in Experimental Visceral Leishmaniasis in Interferon-γ Gene-disrupted Mice

  1997cited by this paper
• Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice

  1997cited by this paper
• Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi.

  1996cited by this paper
• An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.

  1996cited by this paper
• Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.

  1995cited by this paper
• Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjögren's syndrome

  1995cited by this paper
• Effect of treatment with interferon-gamma alone in visceral leishmaniasis.

  1995cited by this paper
• Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection

  1995cited by this paper
• Role and effect of TNF-alpha in experimental visceral leishmaniasis.

  1994cited by this paper
• Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.

  1994cited by this paper
• Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis

  1994cited by this paper
• The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis.

  1993cited by this paper
• Role and effect of IL-2 in experimental visceral leishmaniasis.

  1993cited by this paper
• Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo

  1993cited by this paper
• Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy.

  1993cited by this paper
• Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

  1993cited by this paper
• The Role of Interferon-γ in the Treatment of Visceral and Diffuse Cutaneous Leishmaniasis

  1993cited by this paper
• Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

  1993cited by this paper
• In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.

  1993cited by this paper
• Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani

  1992cited by this paper
• Macrophage deactivation by interleukin 10

  1991cited by this paper
• Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.

  1989cited by this paper
• The dynamics of granuloma formation in experimental visceral leishmaniasis

  1988cited by this paper
• Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.

  1988cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• The effect of treatment with a non-ionic surfactant vesicular formulation of sodium stibogluconate on host immune responses and serum metabolites in a murine model of Leishmania donovani

  2025cites this paper
• An overview of host immune responses against Leishmania spp. infections

  2025cites this paper
• Leishmania donovani infection-driven high levels of IL-10 causes hypoalbuminemia in human visceral leishmaniasis.

  2025cites this paper
• The role of IL-10 in Infected Mice Due to Visceral Leishmaniasis

  2025cites this paper
• Cyclodextrin-AmB-IL-10 antagonist peptide nanoparticles treat leishmaniasis more effectively than conventional AmB.

  2025cites this paper
• Exploring the phytomedicine properties of azadiradione against leishmaniasis: in silico and in vitro insights.

  2025cites this paper
• Host directed immunotherapy for chronic infections and cancer.

  2025cites this paper
• Tick-borne coinfections modulate CD8+ T cell response and progressive leishmaniosis

  2025cites this paper
• IL-10 Plays a Critical Role in Mitigating Acute Anaemia Development During African Trypanosome Infection

  2025cites this paper
• The level of IL-12, IL-10, IL-4, and MMP-13 in cutaneous leishmaniasis patients

  2024cites this paper
• Eimeria: Navigating complex intestinal ecosystems

  2024cites this paper
• Kupffer cell and recruited macrophage heterogeneity orchestrate granuloma maturation and hepatic immunity in visceral leishmaniasis

  2024cites this paper
• An Insight into the Role of IL-10 and Foamy Macrophages in Infectious Diseases.

  2024cites this paper
• Malnutrition disrupts adaptive immunity during visceral leishmaniasis by enhancing IL-10 production

  2024cites this paper
• Malnutrition disrupts adaptive immunity during visceral leishmaniasis by enhancing IL-10 production

  2024cites this paper
• Advancing Treatment for Leishmaniasis: From Overcoming Challenges to Embracing Therapeutic Innovations.

  2024cites this paper
• Diphencyprone reduces the CD8+ lymphocytes and IL-4 and enhences IgG2a/IgG1 ratio in pathogenicity of acute leishmania major infection in BALB/c mice.

  2024cites this paper
• Therapeutic potential of rWnt5A in curbing Leishmania donovani infection

  2022cites this paper
• Chronic Systemic Infection of Mice with Leishmania infantum Leads to Increased Bone Mass

  2022cites this paper
• The Role of MIF and IL-10 as Molecular Yin-Yang in the Modulation of the Host Immune Microenvironment During Infections: African Trypanosome Infections as a Paradigm

  2022cites this paper
• IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette–Guérin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice

  2022cites this paper
• T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis

  2022cites this paper
• The expression of PD-1 and its ligands increases in Leishmania infection and its blockade reduces the parasite burden.

  2022cites this paper
• Leishmaniasis

  2021cites this paper
• Liver- and Spleen-Specific Immune Responses in Experimental Leishmania martiniquensis Infection in BALB/c Mice

  2021cites this paper
• Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity

  2021cites this paper
• Blocking IL-10 signaling with soluble IL-10 receptor restores in vitro specific lymphoproliferative response in dogs with leishmaniasis caused by Leishmania infantum

  2021cites this paper
• Potential biomarkers of immune protection in human leishmaniasis

  2021cites this paper
• Role of Cytokines in Experimental and Human Visceral Leishmaniasis

  2021cites this paper
• Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis.

  2021cites this paper
• Immunological determinants, host immune responses, and animal models of visceral leishmaniasis

  2021cites this paper
• Cytokines and metabolic regulation: A framework of bidirectional influences affecting Leishmania infection.

  2020cites this paper
• Blocking IL-10 signaling with soluble IL-10 receptor restores specific lymphoproliferative response in dogs with leishmaniasis caused by Leishmania infantum

  2020cites this paper
• Modulation of Cytokines and Extracellular Matrix Proteins Expression by Leishmania amazonensis in Susceptible and Resistant Mice

  2020cites this paper
• Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?

  2020cites this paper
• Tongue sole (Cynoglossus semilaevis) interleukin 10 receptors are involved in the immune response against bacterial infection.

  2020cites this paper
• Targeting IL-27 and/or IL-10 in Experimental Murine Visceral Leishmaniasis.

  2020cites this paper
• Hemorheological Evaluation and Cytokine Production in Dogs Naturally Infected with Anaplasmataceae

  2020cites this paper
• Unravelling the unsolved paradoxes of cytokine families in host resistance and susceptibility to Leishmania infection

  2020cites this paper
• Role of host genetics and cytokines in Leishmania infection.

  2020cites this paper
• EBI-3 Chain of IL-35 Along With TGF-β Synergistically Regulate Anti-leishmanial Immunity

  2019cites this paper
• Intestinal nematode infection exacerbates experimental visceral leishmaniasis

  2019cites this paper
• Tinkering with targeting nucleotide signaling for control of intracellular Leishmania parasites.

  2019cites this paper
• Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy

  2019cites this paper
• Biology and therapeutic potential of interleukin-10

  2019cites this paper
• Parasitic load determination by differential expression of 5-Lipoxygenase and PGE2 Synthases in Visceral Leishmaniasis.

  2019cites this paper
• Vaccinia Virus-Derived Vectors in Leishmaniases Vaccine Development

  2019cites this paper
• IL-4 Mediated Resistance of BALB/c Mice to Visceral Leishmaniasis Is Independent of IL-4Rα Signaling via T Cells

  2019cites this paper
• Immunotherapy in clinical canine leishmaniosis: a comparative update.

  2019cites this paper
• In vitro and in vivo immunomodulatory properties of octyl-β-d-galactofuranoside during Leishmania donovani infection

  2019cites this paper
• PDL-1 Blockade Prevents T Cell Exhaustion, Inhibits Autophagy, and Promotes Clearance of Leishmania donovani

  2018influential citation
• Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis

  2018cites this paper
• Drug Discovery for Kinetoplastid Diseases: Future Directions.

  2018cites this paper
• Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases

  2018cites this paper
• Distinct Roles for CD4+ Foxp3+ Regulatory T Cells and IL-10–Mediated Immunoregulatory Mechanisms during Experimental Visceral Leishmaniasis Caused by Leishmania donovani

  2018influential citation
• The impact of IL‐10 dynamic modulation on host immune response against visceral leishmaniasis

  2018cites this paper
• Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N‐terminal domain of Leishmania infantum elongation factor‐2 and CpG oligodeoxynucleotides

  2018cites this paper
• Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.

  2018cites this paper
• Therapeutic vaccine of killed Leishmania amazonensis plus saponin reduced parasite burden in dogs naturally infected with Leishmania infantum.

  2018cites this paper
• Redundant and regulatory roles for Toll‐like receptors in Leishmania infection

  2017cites this paper
• Function of Macrophage and Parasite Phosphatases in Leishmaniasis

  2017cites this paper
• Inflammatory chemokines and their receptors in human visceral leishmaniasis: Gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells

  2017cites this paper
• Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice

  2017cites this paper
• Leishmania infantum Parasites Subvert the Host Inflammatory Response through the Adenosine A2A Receptor to Promote the Establishment of Infection

  2017cites this paper
• Immune Regulation in Human Health and Disease

  2017cites this paper
• Pre-challenge Evaluation of Immune Response in Serum Cytokines (Th1 and Th2) and T-cell Markers (CD4, CD8, CD3, and CD25) Following Administration of New Formulated Leishmania Vaccine in Balb/c Mice

  2017cites this paper
• Protection mediated by chemokine CXCL10 in BALB/c mice infected by Leishmania infantum

  2017cites this paper
• Adenosine generated by ectonucleotidases modulates the host immune system during visceral leishmaniasis

  2017cites this paper
• Interleukin-10 and Interferon-γ Levels in Patients with Cutaneous Leishmaniasis Treated with Cryotherapy

  2017cites this paper
• A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden

  2017cites this paper
• Investigations into the regulation of immune memory resilience

  2016cites this paper
• Post-Genomics and Vaccine Improvement for Leishmania

  2016cites this paper
• Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses

  2016cites this paper
• A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis.

  2016cites this paper
• A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection.

  2016cites this paper
• Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver

  2016cites this paper
• Leishmaniasis and various immunotherapeutic approaches

  2016cites this paper
• Pro- and Anti-inflammatory Cytokines in Visceral Leishmaniasis

  2016cites this paper
• The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis

  2016cites this paper
• Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

  2016cites this paper
• Liposomes containing an ASP49-phospholipase A2 from Bothrops jararacussu snake venom as experimental therapy against cutaneous leishmaniasis.

  2016cites this paper
• IMPACT OF LEISHMANIA DONOVANI INFECTION ON EARLY EVENTS IN HAEMATOPOIESIS

  2016cites this paper
• Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis

  2015cites this paper
• Prophylactic properties of a Leishmania‐specific hypothetical protein in a murine model of visceral leishmaniasis

  2015cites this paper
• Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis.

  2015cites this paper
• IL10-Deficiency in CD4+ T Cells Exacerbates the IFNγ and IL17 Response During Bacteria Induced Colitis

  2015cites this paper
• RECENT STATUS OF ACCESSIBLE DRUGS RESISTANCE IN VISCERAL LEISHMANIASIS

  2015cites this paper
• Correction: Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis

  2015cites this paper
• Th1, Th2 Serum Cytokines and Spleen White Pulp Changes Against Preliminary L. Major Vaccine Injection and Challenge With Live L. Major Promastigotes in Balb/C Mice

  2015influential citation
• International Journal of Pharmaceutical Science and Health Care Issue 5, Vol. 3 (May-June. 2015) Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738

  2015cites this paper
• Leishmania infantum Amastigotes Trigger a Subpopulation of Human B Cells with an Immunoregulatory Phenotype

  2015cites this paper
• Dendritic Cell Control of Immune Responses

  2015cites this paper
• A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis

  2015cites this paper
• One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis

  2015cites this paper
• Transient IL-10 receptor blockade can enhance CD8+ T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen

  2015cites this paper
• Pro- and Anti-inflammatory Cytokines in Visceral Leishmaniasis

  2015cites this paper
• IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine

  2014cites this paper
• Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease

  2014influential citation
• Impairment of T Cell Function in Parasitic Infections

  2014cites this paper
• Oral Treatment with Aqueous Solution of Coffea canephora Induce Protective Immune Response to Reduce Parasite Burden in Experimental Visceral Leishmaniasis

  2014cites this paper